Patent Assignment
Reel/Frame 043349/0639
Change of Name
Recorded: 2017-07-26
Pages: 4
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2015-12-18
Assignee
IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties
(10)
C3'-Methylene Hydrogen Phosphonate Oligomers and Related Compounds
Patent:
6,639,061 →
Application:
09/349,033 →
Aminooxy-Modified Nucleosidic Compounds and Oligomeric Compounds Prepared Therefrom
Modulation of L-Selectin Shedding via Inhibition of Tumor Necrosis Factor Alpha Converting Enzyme (Tace)
Patent:
6,632,667 →
Application:
09/429,096 →
Process for the Preparation of Oligomeric Compounds
Patent:
6,649,750 →
Application:
09/477,878 →
Antisense Modulation of Fas Mediated Signaling
Patent:
6,653,133 →
Application:
09/665,615 →
Methods for Identifying Ligand Binding Sites in a Biomolecule
Patent:
6,653,067 →
Application:
09/791,147 →
Processes of Purifying Oligonucleotides
Methods for Detection of Chloral Hydrate in Dichloroacetic Acid
Regioselective Synthesis of 2'-O-Modified Nucleosides
Activators for Oligonucleotide Synthesis
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.